| dc.contributor.author | Othieno-Abinya, NA | |
| dc.contributor.author | Nyabola, LO | |
| dc.contributor.author | Kiarie, GW | |
| dc.contributor.author | Ndege, R | |
| dc.contributor.author | Maina, JM | |
| dc.date.accessioned | 2013-07-17T06:31:01Z | |
| dc.date.available | 2013-07-17T06:31:01Z | |
| dc.date.issued | 2002 | |
| dc.identifier.citation | ONDOH, MRNYABOLALAMBERT. 2002. Othieno-Abinya NA, Nyabola LO, Kiarie GW, Ndege R, Maina JM.Chronic myeloid leukaemia at the Kenyatta National Hospital, Nairobi.East Afr Med J. 2002 Nov;79(11):593-7.. East Afr Med J. 2002 Nov;79(11):593-7.. : UoN | en |
| dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/48245 | |
| dc.identifier.uri | http://www.ncbi.nlm.nih.gov/pubmed/12630493 | |
| dc.description.abstract | OBJECTIVE:
To determine the clinical and haematological factors associated with treatment and outcome of chronic myeloid leukaemia (CML) at Kenyatta National Hospital.
DESIGN:
Retrospective survey of patients treated for chronic myeloid leukaemia.
SETTING:
Kenyatta National hospital, Nairobi, Kenya, between April 1990 and August 2000.
SUBJECTS:
Patients with chronic myeloid leukaemia.
RESULTS:
One hundred and four patients, 55 males and 49 females, age range 10-72 years with a median age of 35 years. Treatment with busulphan getting less popular in favour of hydroxyurea. Median follow-up 20 months with none of the clinical and haematological parameters impacting significantly on duration of follow-up.
CONCLUSION:
CML occurs at a younger age-group in Kenya, and none of the clinical or haematological parameters appears to impact on follow-up duration. | en |
| dc.language.iso | en | en |
| dc.publisher | University of Nairobi | en |
| dc.title | Chronic myeloid leukaemia at the Kenyatta National Hospital, Nairobi.East Afr Med J. 2002 Nov;79(11):593-7. | en |
| dc.type | Article | en |
